Alan Trefler reports trust transfers, sells ~45k PEGA shares under 10b5-1
Rhea-AI Filing Summary
Alan N. Trefler, CEO and Chairman of Pegasystems Inc. (PEGA), reported multiple internal transfers and routine open-market sales of common stock. The Form 4 shows transfers among several Trefler family trusts and trust formations, including the creation of The Trefler 2025 Trust and movements into an Irrevocable Non-GST Trust of 2022. On 09/16/2025 Mr. Trefler sold 42,672 shares at a weighted average price of $57.79–$58.78 and 2,328 shares at $58.79–$59.25 under a pre-arranged Rule 10b5-1 trading plan. Following the transactions, total reported beneficial ownership remains large (about 45.07 million shares). The filings reflect estate and trust reorganization plus planned, pre-arranged sales rather than opportunistic trading.
Positive
- Use of a Rule 10b5-1 trading plan demonstrates pre-arranged, compliant insider sales and governance controls
- Transparent disclosure of weighted-average sale prices and willingness to provide detailed price-by-price information to the SEC or shareholders
- Transfers are identified as exempt, indicating internal estate/trust reorganizations rather than market disposals
Negative
- Reported open-market sales of 45,000 shares occurred, which provides liquidity to the reporting person
- Complex series of trust transfers may require additional documentation for shareholders seeking clarity on long-term control and succession
Insights
TL;DR: Insider executed planned trust transfers and modest Rule 10b5-1 sales; ownership scale unchanged materially.
These Form 4 entries document internal transfers between multiple grantor retained annuity trusts and irrevocable trusts, plus sales executed under a Rule 10b5-1 plan. The reported open-market disposals total 45,000 shares at weighted-average prices in the high $50 range, while aggregate beneficial ownership remains approximately 45.07 million shares. From a market-impact perspective these sales are small relative to total holdings and consistent with scheduled liquidity or estate planning rather than an operational signal about company performance. Disclosure of the 10b5-1 plan and undertaking to provide price-by-price sale details improves transparency.
TL;DR: Transactions appear to be estate planning and rule-compliant insider sales with appropriate disclosure.
The Form 4 shows exempt transfers among related trusts and the establishment of a 2025 trust, indicating estate or succession planning activity. The CEO sold shares pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2024, and the filing provides weighted-average prices and offers to supply detailed sale breakdowns on request, which aligns with best-practice insider trading controls. No evidence in the form indicates undisclosed related-party transactions or unusual derivative activity.
FAQ
What transactions did PEGA insider Alan Trefler report on the Form 4?
Were any shares sold under a trading plan (10b5-1) by PEGA insider Alan Trefler?
What prices were reported for the PEGA insider sales?
How many PEGA shares does Alan Trefler beneficially own after the transactions?
Do the filings show any derivative transactions by the PEGA reporting person?